View in EDS

Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.

Saved in:
Bibliographic Details
Title: Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study.
Authors: Specchio, N.1,2 (AUTHOR), Marsh, E.3,4 (AUTHOR), Devinsky, O.5 (AUTHOR), Aledo-Serrano, Á.6 (AUTHOR), Battaglia, D. I.7,8 (AUTHOR), Rajaraman, R.9,10 (AUTHOR), Keough, K.11 (AUTHOR), Honda, R.12 (AUTHOR), Guerrini, R.13,14 (AUTHOR), Melikishvili, G.15 (AUTHOR), Amin, S.16 (AUTHOR), Jaksha, A.17 (AUTHOR), Haas, S.18 (AUTHOR), Moseley, B.19 (AUTHOR), Wecker, P. St.20 (AUTHOR), Kilgallen, B.19 (AUTHOR), Dickson, N.19 (AUTHOR), Sullivan, J.21 (AUTHOR)
Source: Neuropediatrics. 2026 Supplement 1, Vol. 57, pS1-S24. 24p.
Database: Academic Search Ultimate
Description
ISSN:0174304X
DOI:10.1055/s-0046-1822867